Treatment (3) Radioimmunotherapy (3) Lymphomas (3) Radioimmunotherapy (3) Days (2) temps (durée) (1) thérapie (1) technologie (1) région (1) radioactivité (1) mutant (1) anticorps (1) gène (1) dose (1) âge (1) cancer (1) abords (agglomération) (1) taux (1) Control (1) Cancer (1) Methods (1) Streptavidin (1) Genes (1) Vascular resistance (1) Tumors (1) Time (1) Therapeutics (1) Technology (1) Series (1) Radioactivity (1)